These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8377343)

  • 21. Angiotensin converting enzyme inhibitors.
    Breckenridge A
    Br Med J (Clin Res Ed); 1988 Feb; 296(6622):618-20. PubMed ID: 2832034
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of angiotensin-converting enzyme inhibitors in hypertension].
    Rahn KH
    Z Kardiol; 1988; 77 Suppl 3():69-71. PubMed ID: 2850690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical efficacy of combined therapy with enalapril + trimetazidine in patients with hypertension comorbid with ischemic heart disease and metabolic disturbances].
    Petelina TI; Gapon LI; Bakhmatova IuA; Zhevagina IA
    Ter Arkh; 2005; 77(8):19-23. PubMed ID: 16206600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An overview of angiotensin-converting enzyme inhibitors in the treatment of hypertension.
    Weber MA
    J Am Osteopath Assoc; 1987 Feb; 87(2 Suppl):175-80. PubMed ID: 3030978
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacokinetic properties and indications for modern vasodilators. 1. Pharmacodynamic properties of vasodilators].
    Langnickel R; Bluth R
    Z Arztl Fortbild (Jena); 1985; 79(19):821-5. PubMed ID: 2866637
    [No Abstract]   [Full Text] [Related]  

  • 26. ACE inhibitors.
    Aust Nurses J; 1988 Aug; 18(2):27-8. PubMed ID: 2848480
    [No Abstract]   [Full Text] [Related]  

  • 27. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
    Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA
    Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neuroprotective activity of angiotensin-converting enzyme inhibitors during cerebral ischemia].
    Kozhevnikova EV; Adzhienko LM
    Biull Eksp Biol Med; 1999 Nov; 128(11):535-7. PubMed ID: 10640241
    [No Abstract]   [Full Text] [Related]  

  • 29. [The use of angiotensin-converting enzyme inhibitors in patients with chronic glomerulonephritis].
    Dudar IO
    Lik Sprava; 1999; (7-8):55-9. PubMed ID: 10672690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin converting enzyme inhibitors--do they have an anti-ischemic action?
    Rutherford JD
    Trans Am Clin Climatol Assoc; 1996; 107():57-66; discussion 66-7. PubMed ID: 8725560
    [No Abstract]   [Full Text] [Related]  

  • 31. [Inhibition of angiotensin converting enzyme as a therapeutic approach: the pros and cons].
    Waeber B; Waeber G; Nussberger J; Brunner HR
    Rev Med Brux; 1986 Apr; 7(4):227-30. PubMed ID: 3014629
    [No Abstract]   [Full Text] [Related]  

  • 32. ACE inhibitors improve compliance.
    Gever LN
    Nursing; 1987 Oct; 17(10):143. PubMed ID: 2821461
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hypertensive patient with diabetes. "Blood pressure cosmetics" are not enough here].
    MMW Fortschr Med; 2002 Jun; 144(24):53. PubMed ID: 12138889
    [No Abstract]   [Full Text] [Related]  

  • 34. [Do we need more ACE inhibitors?].
    Haugen O
    Tidsskr Nor Laegeforen; 1990 Apr; 110(11):1411. PubMed ID: 2187274
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardioprotection by angiotensin-converting enzyme (ACE) inhibitors.
    Juggi JS; Koenig-Berard E; Van Gilst WH
    Can J Cardiol; 1993 May; 9(4):336-52. PubMed ID: 8513428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Converting enzyme inhibitors in preterminal renal failure].
    Rambausek MH; Ritz E
    Dtsch Med Wochenschr; 1992 Jan; 117(2):77. PubMed ID: 1730207
    [No Abstract]   [Full Text] [Related]  

  • 37. [Mechanisms of action and clinical use of converting enzyme inhibitors].
    Lazowski J; Rewerski W
    Pol Tyg Lek; 1986 Dec; 41(48):1507-11. PubMed ID: 3035518
    [No Abstract]   [Full Text] [Related]  

  • 38. [Control of myocardial ischemia in patients with effort angina and polyvascular atherosclerotic involvement].
    Saiutina EV; Chigineva VV; Zolozova EA; Karlova NA; Karlov AA; Pshenitsin AI; Mazur NA
    Kardiologiia; 2012; 52(8):15-9. PubMed ID: 23098393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin converting enzyme inhibitors in angina and myocardial infarction. What role will they play in the 1990s?
    Ertl G
    Drugs; 1993 Aug; 46(2):209-18. PubMed ID: 7691512
    [No Abstract]   [Full Text] [Related]  

  • 40. [Converting enzyme inhibitors in the treatment of essential hypertension].
    Sancho Rof J
    Med Clin (Barc); 1985 Nov; 85(14):578-80. PubMed ID: 3001445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.